Frequency of Outpatient Inhalers Prescriptions in Riyadh

Main Article Content

Nehad J. Ahmed
Mohd F. Khan


Background: Community pharmacists help patients in making informed decisions about their treatment and prevent the problems that could be developed from self-medication. The maintenance therapy with inhaled medications is the keystone of pharmacotherapy in many respiratory diseases such as asthma and chronic obstructive pulmonary disease.

Aim: The aim of the present study was to explore the frequency of inhalers dispensing in Riyadh.

Methodology: This was a cross-sectional, observational study carried out in Riyadh city to analyze the prescriptions in outpatient pharmacies.

Results and Discussion: The total number of prescriptions is 198 prescriptions that include 650 different medications. Out of the 650 medications, the majority were in the form of a tablet (61.7%), followed by capsules. The present study showed that the use of inhalers was uncommon in Riyadh. Out of 650 drugs, 27 drugs were available as inhalers (4.15%). Out of 27 Inhalers, Ventolin inhalers is the most prescribed (48.14%), followed by Seretide Evohaler (29.62%) and Symbicort Turbuhaler (22.2%).

Conclusion: Although there is a high prevalence of respiratory diseases, inhaler prescriptions and dispensing aren’t common. This may be due to the use of these inhalers as OTC drugs. The role of pharmacists should be to dispense the regular medications only by prescriptions and to counsel patients about the information regarding the use of inhalers.

Outpatient, inhalers, prescriptions, Riyadh.

Article Details

How to Cite
Ahmed, N. J., & F. Khan, M. (2019). Frequency of Outpatient Inhalers Prescriptions in Riyadh. Journal of Pharmaceutical Research International, 31(6), 1-5.
Original Research Article


Bennadi D. Self-medication: A current challenge. Journal of Basic and Clinical Pharmacy. 2013;5(1):19-23.
DOI: 10.4103/0976-0105.128253

You JH, Wong FY, Chan FW, Wong EL, Yeoh EK. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clinical Pharmacology. 2011;11:19-19.
DOI: 10.1186/1472-6904-11-19

Catic T, Jusufovic FI, Tabakovic V. Patients perception of community pharmacist in bosnia and herzegovina. Mater Sociomed. 2013;25(3):206- 209.
DOI: 10.5455/msm.2013.25.206-209

Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-543.

Gibbs KP, Small M. Asthma. In: Walker R, Edwards C, editors. Clinical pharmacy and therapeutics. 3rd Ed. Philadelphia: Churchill Livingstone. 2003;375–395.

Gibbs KP, Small M. Chronic obstructive pulmonary disease. In: Walker R, Edwards C, editors. Clinical pharmacy and therapeutics. 3rd Ed. Philadelphia: Churchill Livingstone. 2003;397–411.

Global initiative for asthma guidelines; 2015.

Chronic obstructive pulmonary disease, guidelines; 2015.
Available: Guidelineitem.asp

Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. The Lancet. 2018; 391(10122):783-800.

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Murray CJL. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990– 2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2163-2196.
DOI: 10.1016/S0140-6736(12)61729-2

Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14-23.
DOI: 10.1111/resp.12660

British Lung Foundation. Chronic obstructive pulmonary disease (COPD). Statistics; 2017.

Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, Price D. Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach. Respir Med. 2013; 107(12):1817-1821.

NICE Guideline NG80. Asthma: diagnosis, monitoring and chronic asthma management; 2017.
[Cited 2019 Mar 20]

British guideline on the management of asthma; 2016.
[Cited 2019 Mar 18]

Principles of Prescribing in Adult Asthma; 2018.
[Cited 2019 Mar 20] [Google Scholar]
Available: documents1—all-documents/nhsgmcn_asthma.pdf

NHS Grampian respiratory MCN – principles of prescribing inhaled therapies in COPD; 2018.
[Cited 2019 Mar 21]
Available: file:///C:/Users/mail/Desktop/My%20documents/Ongoing%20papers/Scotland%20Respiratory/nhsgmcn_copd.pdf

GOLD. Teaching slide set; 2018.
[Cited 2019 Mar 21] [Google Scholar]

Moradi-Lakeh M, El Bcheraoui C, Daoud F. Tuffaha M, Kravitz H, Al Saeedi M, Mokdad AH. Prevalence of asthma in Saudi adults: Findings from a national household survey, 2013. BMC Pulmonary Medicine. 2015;15(1):77.
DOI: 10.1186/s12890-015-0080-5

Al Ghobain MO, Algazlan SS, Oreibi TM. Asthma prevalence among adults in Saudi Arabia. Saudi Med J. 2018;39(2):179- 184.

Al Ghobain M, Alhamad EH, Alorainy HS, Al Kassimi F, Lababidi H, Al-Hajjaj MS. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: A Bold study. Int J Tuberc Lung Dis. 2015;19(10):1252-1257.
DOI: 10.5588/ijtld.14.0939

Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the Critikal study: Type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5:1071.

Medicine Net. Asthma: List of OTC asthma medications and Inhalers; 2019.
[Online] [Accessed 12 Nov. 2019]